JD Health (06618) Launches Evidence-Based Medical AI Product "Zhiyi" to Support Doctors in Clinical and Research Settings

Stock News
01/17

On January 17, the 2026 JD Health Annual Doctor Summit was grandly held in Beijing. At the event, JD Health significantly launched "Zhiyi," an evidence-based medical AI product specifically designed for doctors. According to the introduction, this product focuses on two core scenarios: clinical decision-making and academic research, deeply integrating tens of millions of authoritative global medical data points. It can rapidly screen and highly synthesize vast amounts of authoritative literature and guidelines, directly outputting actionable conclusions to enhance the quality and efficiency of doctors' clinical diagnosis and treatment, while providing robust support for scientific research exploration. It is reported that "Zhiyi" will be fully integrated into the JD Doctor APP and made available for all doctors to experience; regardless of whether they are affiliated with JD Internet Hospital, they can utilize this evidence-based medical AI product.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10